Advertisement · 728 × 90

Posts by John Walton Muscular Dystrophy Research Centre

Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment - Cell Death & Disease Cell Death & Disease - Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment

Congratulations to the team for a new paper published 👏

🧫By combining advanced co-culture systems, secretome profiling, and 3D engineered muscle models, we investigated how #Duchenne muscular dystrophy (DMD)-derived FAPs inhibit myogenesis.

bit.ly/3PE1Hpv

2 weeks ago 0 0 0 0
Preview
PaLaDIn Newsletter March 2026 What’s in this edition? Promptly Health and PaLaDIn collaborate to build the Interactium® PaLaDIn at TREAT-NMD’s 8th International Conference in Lisbon PaLaDIn and Rare Disease Day 2026 PaLaDIn at Par...

Check out the latest PaLaDIn Newsletter March 2026 to catch up on recent work on the project and developments in the Interactium platform! 👀

www.linkedin.com/pulse/paladi...

3 weeks ago 0 0 0 0
Post image

One of our Strand Leads, Prof Michela Guglieri, presenting "gene therapy in muscle diseases" as part of a series of seminars in Padova on neurology topics; “martedì della clinica neurologica” meaning "Tuesdays of the neurology clinic" 😀

3 weeks ago 0 0 0 0
Preview
Assessing the Relationship of Quality of Life With Functional Status in a Large Cohort of Adult Patients With Neuromuscular Disorders | Neurology Clinical Practice Background and ObjectivesHealth-related quality of life (HR-QoL) is compromised in patients with neuromuscular disorders (NMDs). Disease severity alone does not predict HR-QoL; there are other known p...

📢Another paper to celebrate! This one, authored entirely by members of the JWMDRC, aims to provide insight into how mobility, age, and diagnosis may affect health-related quality of life in adults with neuromuscular disease👏

www.neurology.org/doi/pdf/10.1...

1 month ago 1 1 0 0
Preview
Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies Objective Sarcoglycanopathies are among the most severe limb-girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense vari...

We are pleased to announce a new publication "Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies" which aimed to establish accurate genotype–phenotype correlations for LGMDR3, LGMDR4, and LGMDR5 👏

bit.ly/4lGc1sL
#LGMD

1 month ago 1 0 0 0
Post image

We’re delighted to be at Muscular Dystrophy UK’s Birmingham Information Day on Sat 14 March — a free event for adults and parents of children with muscle‑wasting conditions.

We’ll be representing JWMDRC and sharing the work of our Registries Team.

Sign up here: bit.ly/4rj0CQM

1 month ago 2 0 0 1
Post image

Thrilled to announce our paper has been accepted in the Journal of Neuromuscular Disorders. This was a fantastic effort bringing the efforts of patient community, registry and researchers together to learn more about liver health in MTM-CNM patients

bit.ly/4rKvfQd

1 month ago 3 0 0 1
Advertisement
Post image

📢 New paper published, "Respiratory function in Becker muscular dystrophy: a comprehensive longitudinal study" which informs clinical surveillance strategies & care recommendations, and supports the design & interpretation of clinical trials in #BMD 🙌

bit.ly/4chzdLr

1 month ago 1 1 0 1
Post image

Our national and international #neuromuscular patient registries are proud to support #RareDiseaseDay!

Learn more about our work at jwmdrc.org/networking/registries

#LightUpForRare #ShareYourColours

1 month ago 4 3 0 0
LinkedIn This link will take you to a page that’s not on LinkedIn

📢NOW OPEN!
The NIHR Newcastle PSRC Pre-Application Support Fund is now live.
Attend info webinar - 12th February 13:00 - 14:00. psrc-ncl.nihr.ac.uk/academic-car...
Deadline: 13th March.
@newcastleuni.bsky.social @nclpharmacy.bsky.social @medicalsciencesncl.bsky.social @nihrpsrcs.bsky.social

2 months ago 5 5 0 1
Post image

📢 New academic initiative aimed at characterizing multisystem proteinopathies

We invite colleagues worldwide who have diagnosed patients with genetic variants in MSP-associated genes to participate in this international collaboration

Find out more: bit.ly/4qjIRkH

3 months ago 0 1 0 0
Client Challenge

A new year, a new paper!

Congratulations to the Basic Research team for this paper on unknown molecular interactions of EGFR that drive muscle degeneration in #DMD

These insights open the door to targeted therapies that could help slow muscle degeneration in muscle dystrophies

bit.ly/4sINHKe

3 months ago 0 1 0 0
Post image

Proud to partner with @eurordis for #ECRD2026, Europe’s largest patient-led rare disease event. Join us in Prague & online, 3–4 June 2026. Poster abstracts now open! 👉 www.rare-diseases.eu/posters

5 months ago 1 1 0 0
Post image

Applications are open to join the PaLaDIn Patient and Caregiver User Group (PCUG).

We're looking for #patients and #caregivers with experience of a #neuromuscular disease to join and contribute.

Further information is available here: bit.ly/47V9DrS

5 months ago 0 0 0 0
Post image

We have a strong attendance at #WMS2025 on its 30th birthday, and this is the last year for our Centre Director, Prof. Volker Straub, as President.

Volker gave the Congress Welcome this morning, inviting everyone to have an enjoyable and productive few days here in Vienna

6 months ago 4 0 0 0
Post image

📢New projects feature in the #LGMD News Autumn edition. Produced for the community by The Speak Foundation, this is a great resource for members of the LGMD community🙌

See page 14 for an article about new projects at our centre!

📰Sign up here: bit.ly/4pWGsNl

6 months ago 3 1 0 0
Advertisement
Post image

Today we're supporting #LGMD Awareness Day! 🙌

While we can't reverse LGMD yet, proper care, support, and therapies can make a world of difference. Let's advocate for accessible care for all living with LGMD.

#LGMDday2025 #lgmdawarenessday

6 months ago 1 0 0 0
Post image Post image Post image Post image

Today at the FSHD Annual Engagement Day experts from NuTH are giving useful talks on pain management, sleep issues and exercise prescription👩‍⚕️

We're also getting research updates from the lab team on FSHD mechanisms, lab studies and imaging projects👨‍🔬

#FSHD

6 months ago 1 1 0 0
Post image

Today we're supporting international myotonic dystrophy awareness day! #MyotonicDystrophy (DM) is an inherited multisystem condition that mainly causes progressive muscle loss, weakness and myotonia. Join us in raising awareness and supporting research: bit.ly/41Wng82

7 months ago 0 1 0 0
Post image

⭐£22M NIHR investment to strengthen UK health & life sciences innovation

We are delighted that @nihr-io.bsky.social at @newcastleuni.bsky.social has been awarded £22M by @nihr.bsky.social to continue research identifying emerging medicines, diagnostics, devices & digital tech
👉 ow.ly/ooyc50WPtFj

7 months ago 7 3 0 2
Post image

🎈 On World Duchenne Awareness Day, we stand with the #Duchenne & #Becker Muscular Dystrophy community.

At JWMDRC, we’re committed to advancing care, research & inclusion—because Duchenne is a lifelong journey.

#WDAD2025

7 months ago 0 0 0 0
Post image

FSHD Annual Engagement Day – 25 Sept, Newcastle

🔬 Research updates
🩺 Clinical sessions
👩‍⚕️ 1:1 consultations
💬 Last year: “high quality, interactive & informative”

Book now: rb.gy/gabmw7

#FSHD

7 months ago 1 0 0 0
Post image

Our director Volker Straub receiving the LGMD Innovator award from Kelly Brazzo from CureLGMD2i at the International LGMD Conference in Orlando on 19th July 👏🥳

#LGMD

8 months ago 0 0 0 0
Advertisement
Post image

We're looking for children & adults with Nemaline Myopathy to join a study to collect data on the natural progression of the condition.

Help us understand Nemaline Myopathy to be ready for therapeutic developments

See more at bit.ly/3HeoRPc

#NemalineMyopathy #RareDisease

8 months ago 0 0 0 0
Preview
Search for Postgraduate Scholarships and Other Funding Search scholarships and funding for postgraduate study at Newcastle University. Find financial support tailored to your course and eligibility.

🔍 Want to model rare disease progression using #ArtificialIntelligence & #ML? Join a PhD at Newcastle Uni tackling FSHD with #bioinformatics + #MachineLearning. Part of LifeArc ARDT’s £12m UK-wide initiative.

To apply: bit.ly/4eVKUqe

9 months ago 2 1 0 0
Post image

Join us for the FSHD Engagement Day in Newcastle on 25 Sept 2025! Connect with others, hear from experts & explore key aspects of life with FSHD.

Book your place: rb.gy/gabmw7

#FSHD #FSHDUK #FSHDEurope #WorldFSHDDay

10 months ago 2 0 1 1
Video

Now for our big news... I'm delighted to announce that the UK FSHD Patient Registry has now 🌟 RELAUNCHED 🌟 onto our new bespoke registry platform, with improved questionnaires and features!

Visit our website to learn more and sign up today!

👀 www.fshd-registry.org.uk 👀

#FSHD #WorldFSHDday

10 months ago 4 3 0 0
Video

We were fortunate to attend the @fshdsociety.bsky.social International Research Congress and FSHD Europe Patient Connect meetings last week.

These fantastic events brought together the FSHD community across Europe to make new connections and share research advancements #WorldFSHDday

10 months ago 4 2 0 0
Video

🍊 Today is World FSHD Day!

📅 Held on June 20th to raise public awareness of #FSHD

🧬 Our Patient Registry helps advance research and development of treatments, therapies, and care for all those diagnosed with FSHD in the UK.

💻 Visit our newly revamped website to learn more: fshd-registry.org.uk

10 months ago 2 3 0 0
Preview
PaLaDIn Interactium® Data Platform: Invitation to Tender - Project PaLaDIn We are now pleased to announce the opening of the Invitation to Tender stage for the development of the Interactium®.

The JWMDRC is proud to support the launch of the PaLaDIn Interactium data platform tender! Bids are open till 17 July—help us shape the future of rare disease data infrastructure.

More info 👉 project-paladin.eu/paladin-inte...

10 months ago 1 0 0 0